14 September 2018
Clifford Chance advises The Carlyle Group in acquiring majority stake in East African pharmaceutical leader
International law firm Clifford Chance has advised global alternative asset manager The Carlyle Group on the acquisition of a majority stake in AK Life Sciences (Abacus), a leading distributor of pharmaceutical products in East Africa and the largest manufacturer of parenterals in Uganda. Financial terms of the deal are not disclosed.
In recent years, Clifford Chance have advised The Carlyle Group in a number of markets, including the asset manager's investments into Ant Financial and Baidu FSG in China, its acquisition of Accolade Wines in Australia and its sale of Sagemcom to Charterhouse Capital partners LLP in France.
Nigel Wellings, Partner and Co-Head of London Corporate Practice, led the transaction team, and was supported by senior associate Danny Mutisya and associate Alex Ward.